PPNK Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | O95544 |
---|---|
Clone Names | 4012801 |
Gene ID | 65220 |
---|---|
Other Names | NAD kinase, Poly(P)/ATP NAD kinase, NADK |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP7176a was selected from the N-term region of human PPNK. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NADK |
---|---|
Tissue Location | Widely expressed but not detected in skeletal muscle. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
NADP is essential for biosynthetic pathways, energy, and signal transduction. Its synthesis is catalyzed by NAD kinase, which phosphorylates NAD+ to form NADP+. The NAD kinase gene is expressed in most human tissues, but not in skeletal muscle. The catalytically active homotetramer is highly selective for its substrates, NAD and ATP.
References
Lerner, F., et al., Biochem. Biophys. Res. Commun. 288(1):69-74 (2001).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.